National Health Investors Inc. (NYSE:NHI) shares fell to a low of $65.56 before closing at $65.56. Intraday shares traded counted 0.44 million, which was -39.36% lower than its 30-day average trading volume of 317.04K. NHI’s previous close was $66.57 while the outstanding shares total 45.30M. The firm has a beta of 0.95, a 12-month trailing P/E ratio of 18.45, and a growth ratio of 1.84. The stock’s Relative Strength Index (RSI) is 31.21, with weekly volatility at 1.76% and ATR at 1.49. The NHI stock’s 52-week price range has touched low of $53.70 and a $78.56 high. The stock traded lower over the last trading session, losing -1.52% on 05/27/21.
Investors have identified the REIT – Healthcare Facilities company National Health Investors Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $3.00 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
National Health Investors Inc. (NHI) Fundamentals that are to be considered.
NHI were able to record 55.46 million as free cash flow during the 08/11/2021 quarter of the year, this saw their quarterly net cash flow reduce by 69.89 million. In cash movements, the company had a total of 56.91 million as operating cash flow.
Potential earnings growth for National Health Investors Inc. (NHI)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/11/2021 quarter of the year, National Health Investors Inc. recorded a total of 80.89 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with -2.71% coming in sequential stages and their sales for the 08/11/2021 quarter reducing by -0.46%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 31.27 million trying to sell their products during the last quarter, with the result yielding a gross income of 49.62 million. This allows shareholders to hold on to 45.30M with the recently reported earning now reading 0.78 cents per share. This is a figure that compared to analyst’s prediction for their 08/11/2021 (1.24 cents a share).
Having a look at the company’s valuation, the company is expected to record 5.63 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on NHI sounds very interesting.
Is the stock of NHI attractive?
In related news, Director, ADAMS ROBERT G bought 2,000 shares of the company’s stock in a transaction that recorded on Dec 14. The purchase was performed at an average price of 67.75, for a total value of 135,500. As the purchase deal closes, the Director, ADAMS ROBERT G now bought 4,000 shares of the company’s stock, valued at 265,320. Also, Director, ADAMS ROBERT G bought 1,000 shares of the company’s stock in a deal that was recorded on Nov 17. The shares were cost at an average price of 66.45 per share, with a total market value of 66,450. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.50%.
0 out of 10 analysts covering the stock have rated it a Buy, while 8 have maintained a Hold recommendation on National Health Investors Inc.. 1 analysts has assigned a Sell rating on the NHI stock. The 12-month mean consensus price target for the company’s shares has been set at $70.50.